Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?-Reference-Cited by-同舟云学术

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Published:2012-05 Issue:3 Volume:11 Page:173-179
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Ashish Abdul,Shaw Matthew,Winstanley C.,Ledson Martin J.,Walshaw Martin J.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference44 articles.

1. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa;Kerem;J Pediatr,1990

2. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis;Henry;Pediatr Pulmonol,1992

3. Lung transplantation for cystic fibrosis;Zuckerman;Clin Chest Med,1998

4. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic;Cheng;Lancet,1996

5. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents;Pitt;Thorax,2003

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel application of metagenomics for the strain-level detection of bacterial contaminants within non-sterile industrial products – a retrospective, real-time analysis;Microbial Genomics;2022-11-24

2. Liverpool Epidemic Strain Isolates of Pseudomonas aeruginosa Display High Levels of Antimicrobial Resistance during Both Planktonic and Biofilm Growth;Microbiology Spectrum;2022-06-29

3. Pseudomonas aeruginosa Alters Peptidoglycan Composition under Nutrient Conditions Resembling Cystic Fibrosis Lung Infections;mSystems;2022-06-28

4. Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide;Advanced Science;2022-01-14

5. The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF);Journal of Cystic Fibrosis;2021-11